Loss of FOXA1/2 is Essential for the Epithelial-to-mesenchymal Transition in Pancreatic Cancer
Overview
Affiliations
FOXA1 and FOXA2, members of the forkhead transcription factor family, are critical for epithelial differentiation in many endoderm-derived organs, including the pancreas. However, their role in tumor progression is largely unknown. Here, we identified FOXA1 and FOXA2 as important antagonists of the epithelial-to-mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDA) through their positive regulation of E-cadherin and maintenance of the epithelial phenotype. In human PDA samples, FOXA1/2 are expressed in all epithelia from normal to well-differentiated cancer cells, but are lost in undifferentiated cancer cells. In PDA cell lines, FOXA1/2 expression is consistently suppressed in experimental EMT models and RNAi silencing of FOXA1/2 alone is sufficient to induce EMT. Conversely, ectopic FOXA1/2 expression can potently neutralize several EMT-related E-cadherin repressive mechanisms. Finally, ectopic FOXA2 expression could reactivate E-cadherin expression in a PDA cell line with extensive promoter hypermethylation. In fact, demethylation-mediated reactivation of E-cadherin expression in these cells required concurrent reactivation of endogenous FOXA2 expression. We conclude that suppression of FOXA1/2 expression is both necessary and sufficient for EMT during PDA malignant progression.
The transcription factor FOXQ1 in cancer.
Koch S Cancer Metastasis Rev. 2025; 44(1):22.
PMID: 39777582 PMC: 11711781. DOI: 10.1007/s10555-025-10240-y.
Ueda H, Takahashi H, Kobayashi S, Kubo M, Sasaki K, Iwagami Y Ann Surg Oncol. 2024; 32(2):720-735.
PMID: 39269634 DOI: 10.1245/s10434-024-16115-w.
Strnadel J, Valasek M, Lin G, Lin H, Tipps A, Woo S Hum Cell. 2024; 37(5):1593-1601.
PMID: 39103560 PMC: 11341600. DOI: 10.1007/s13577-024-01113-7.
Wu Z, Ke Q, Jiang L, Hong H, Pan W, Chen W Cell Death Dis. 2024; 15(6):422.
PMID: 38886389 PMC: 11183149. DOI: 10.1038/s41419-024-06800-9.
FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.
Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M Cell Death Discov. 2024; 10(1):172.
PMID: 38605023 PMC: 11009302. DOI: 10.1038/s41420-024-01936-1.